Georgia Behavioral Health

GBH TRD Clinic | Norcross, GA

Treatment-Resistant Depression: When Antidepressants Stop Working, There Are Options

If you have tried two or more antidepressants without meaningful relief, you may have treatment-resistant depression. GBH specializes in advanced, evidence-based treatments designed specifically for patients like you.

30%
of people with major depressive disorder do not respond adequately to antidepressants
Journal of Clinical Psychiatry, 2025
2.8M
adults in the US are estimated to have treatment-resistant depression
Journal of Clinical Psychiatry, 2025
$92.7B
annual economic burden of medication-treated major depressive disorder in the US
Journal of Clinical Psychiatry, 2025

What Is Treatment-Resistant Depression?

Treatment-resistant depression (TRD) is defined as depression that has not responded adequately to at least two different antidepressant treatments taken at appropriate doses and for an appropriate duration. As a result, it is one of the most common yet underdiagnosed conditions in psychiatry.

In fact, TRD is not a character flaw, and it is not a sign that someone is beyond help or has not tried hard enough. Rather, it is a neurological reality that requires a more targeted clinical approach than standard antidepressant therapy can provide.

Research published in Frontiers in Psychiatry (2025) estimates TRD prevalence at 30 to 40 percent of patients treated with antidepressants, making it far more common than most people, and many clinicians, realize.

Source: Frontiers in Psychiatry, 2025

If antidepressants have stopped working, never worked, or stopped working after a period of improvement, that is not the end of the road. It is a clinical signal that a different approach is needed.

Signs You May Have Treatment-Resistant Depression

Many people with TRD have been struggling for years without a clear name for what they are experiencing. They have tried medications, and while some worked partially, others stopped working over time or never produced meaningful relief at all.

You may be experiencing treatment-resistant depression if you:

  • Have tried two or more antidepressants without significant improvement
  • Felt better initially on a medication, but noticed symptoms returning over time
  • Continue to experience depression despite being consistent with treatment
  • Have cycled through multiple medications with diminishing results
  • Experience side effects that make it difficult to stay on your prescribed medication
  • Feel emotionally flat or numb rather than genuinely improved
  • Struggle to function at work, in relationships, or in daily life despite being on medication
  • Have a history of trauma, chronic stress, or co-occurring conditions like PTSD or ADHD

If any of these resonate, a comprehensive psychiatric evaluation at our TRD Clinic is an important next step. Read more about signs your antidepressant is not working.

Why Antidepressants Stop Working

Most traditional antidepressants work by targeting the serotonin system in the brain. For many patients, this approach produces meaningful improvement. However, depression is not a single, uniform condition, and serotonin is only one of several systems involved.

Additionally, research increasingly shows that other brain systems, including the glutamate system and specific neural circuits involved in mood regulation, play a significant role in depression, especially in cases that do not respond to serotonin-based medications. As a result, patients whose depression is rooted in these other systems may find that traditional antidepressants have a ceiling on what they can accomplish.

The Role of Chronic Stress in Treatment Resistance

Beyond brain chemistry, chronic stress is one of the most significant and underrecognized drivers of treatment resistance. When stress becomes chronic, it physically changes the structure of the brain in ways that make depression harder to treat with standard antidepressants.

A 2025 study published in the International Journal of Molecular Sciences found that prolonged HPA axis activation disrupts cortisol regulation and leads to neurobiological changes in the hippocampus that are directly linked to the development and persistence of depressive disorders that do not respond to standard treatment.

Source: International Journal of Molecular Sciences, 2025

Furthermore, neuroinflammation driven by chronic stress affects up to 27 percent of patients with major depressive disorder and is associated with a more severe, treatment-resistant trajectory. Because of this, standard antidepressants, which do not directly address inflammatory pathways, are less effective for this population. Learn more about the link between chronic stress and treatment-resistant depression and why antidepressants stop working.

A woman standing overwhelmed in a busy crowd, representing the anxiety and isolation of untreated depression and mood disorders requiring advanced psychiatric care at Georgia Behavioral Health

Image source: Adobe Stock (Asset ID: AdobeStock_221688877)

Advanced Treatment Options at GBH's TRD Clinic

Treatment-resistant depression is highly treatable with the right approach. In fact, at Georgia Behavioral Health, we offer advanced treatment options that work through entirely different mechanisms than traditional antidepressants, designed specifically for patients who have not found relief through medication alone.

TMS Therapy

FDA-cleared, non-invasive brain stimulation that uses magnetic pulses to target and reset mood-regulating circuits. No sedation required. Patients return to daily activities immediately.

Learn about TMS Therapy

SPRAVATO (Esketamine)

FDA-approved nasal spray targeting the glutamate system for rapid relief of TRD symptoms. Can produce measurable improvement in some patients within hours of the first session.

Learn about SPRAVATO

IV Ketamine Therapy

Fast-acting infusion treatment targeting the brain's glutamate system. Significant results for patients who have not responded to traditional medications.

Learn about IV Ketamine

Psychiatric Care

Comprehensive evaluations and medication management that look beyond a single diagnosis to understand the full clinical picture, including co-occurring conditions.

Learn about Psychiatric Care

EMDR Therapy

For patients where trauma or adverse experiences are driving or compounding depression, EMDR addresses root psychological drivers that medication alone cannot reach.

Learn about EMDR

Talk Therapy

Evidence-based psychotherapy used alongside medical treatment to address stress patterns, cognitive responses, and nervous system regulation for more durable outcomes.

Learn about Talk Therapy

Not sure which treatment is right for you? Read our comparison of TMS therapy vs SPRAVATO to understand the differences, or schedule a comprehensive evaluation and we will help you find the right path forward.

You Have Not Run Out of Options

If antidepressants have not worked for you, that is a clinical signal, not a life sentence. Our TRD Clinic serves patients across Atlanta, Norcross, Johns Creek, Duluth, and Gwinnett County.

Book a Consultation
Person tearing a paper with the word depression on it, representing hope and recovery from treatment-resistant depression through advanced treatment options at Georgia Behavioral Health in Atlanta

Image source: Adobe Stock (Asset ID: AdobeStock_129682464)

Co-Occurring Conditions That Complicate Treatment

Depression rarely exists in isolation. In fact, co-occurring conditions can significantly affect treatment response and are an important part of any comprehensive TRD evaluation. When these conditions go unidentified, patients may cycle through medications without ever addressing the full clinical picture.

Conditions commonly seen alongside TRD include:

  • PTSD: Antidepressants may address some depressive symptoms while leaving underlying trauma unresolved
  • ADHD: Mood dysregulation related to ADHD can mimic or worsen depression and may not respond to standard antidepressant therapy
  • Generalized Anxiety Disorder: Complicates the clinical picture and affects which treatments are most appropriate
  • Bipolar Disorder: Sometimes misdiagnosed as major depressive disorder, leading to treatments not matched to the actual condition
  • Chronic pain or inflammatory conditions: Emerging research connects systemic inflammation to depression that does not respond to serotonin-based treatment

Because of this, a comprehensive psychiatric evaluation that looks beyond depression alone is essential to understanding why treatment may not be working and what approach is most likely to help.

TRD Resources and Research

Are You a Clinician or Therapist?

Download our TRD Clinic Referral Guide for information on referring patients to our practice. We serve Atlanta, Norcross, Johns Creek, Duluth, and the greater Gwinnett County area.

Download Referral Guide

Frequently Asked Questions

What qualifies as treatment-resistant depression?
Treatment-resistant depression is clinically defined as depression that has not responded adequately to at least two different antidepressant treatments at appropriate doses and for an appropriate duration. It does not mean treatment has failed permanently. It means the current approach needs to change.
Is treatment-resistant depression curable?
Many patients with TRD achieve significant, lasting improvement with advanced treatment options. While some individuals require ongoing management, the condition is highly treatable when approached with the right combination of evaluation, medication, and advanced interventions such as TMS therapy, SPRAVATO, or IV ketamine therapy.
How common is treatment-resistant depression?
Research suggests that approximately 30 percent of people with major depressive disorder do not achieve adequate relief from traditional antidepressants. A 2025 study estimated that 2.8 million adults in the United States have treatment-resistant depression, making it far more prevalent than most people realize.
What is the difference between SPRAVATO and traditional antidepressants?
SPRAVATO (esketamine) works on the glutamate system in the brain rather than the serotonin system targeted by most traditional antidepressants. This different mechanism of action is why SPRAVATO can be effective for patients who have not responded to serotonin-based medications. It is FDA-approved for treatment-resistant depression and can produce rapid symptom relief, sometimes within hours of the first treatment session.
Does TMS therapy require medication or sedation?
No. TMS therapy is a non-invasive, FDA-cleared treatment that does not require medication or sedation. Patients remain fully awake throughout the session, which typically lasts 20 to 40 minutes, and can drive themselves home and return to normal activities immediately after treatment.
Does Georgia Behavioral Health accept insurance for TRD treatment?
Coverage varies by plan and treatment type. We encourage patients to contact our office directly at (678) 861-6463 to discuss insurance, coverage, and payment options for their specific treatment plan.
Where is the GBH TRD Clinic located?
Georgia Behavioral Health is located at 4720 Peachtree Industrial Blvd, Suite 4101, Norcross, GA 30071. We serve patients from Atlanta, Norcross, Johns Creek, Duluth, Peachtree Corners, and the greater Gwinnett County area.